Osteologix

Osteologix Inc. Announces Plans to File for European Marketing Authorization for Proprietary Osteoporosis Drug

GLEN ALLEN, Va.–(BUSINESS WIRE)–Osteologix Inc. (OLGX.OB) announced today that the company anticipates that it will be prepared to file a…